Qlife Holding AB (publ) (STO:QLIFE)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.880
-0.042 (-2.19%)
Apr 29, 2026, 12:28 PM CET
0.53%
Market Cap 55.50M
Revenue (ttm) 324.00K
Net Income (ttm) -20.56M
Shares Out 28.87M
EPS (ttm) -1.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,337
Average Volume 39,040
Open 1.944
Previous Close 1.922
Day's Range 1.828 - 1.944
52-Week Range 1.205 - 5.740
Beta 0.57
RSI 46.40
Earnings Date May 1, 2026

About Qlife Holding AB

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Its biomarkers include CRP/C-reactive protein, procalcitonin, Nt-pro-BNP, lipids, HbA1c/D-vitami, and D-dimer. Qlife Holding AB (publ) was incorporated in 2019 and is based in Helsingborg, Sweden. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2019
Employees 4
Stock Exchange Nasdaq Stockholm
Ticker Symbol QLIFE
Full Company Profile

Financial Performance

In 2025, Qlife Holding AB's revenue was 324,000, an increase of 548.00% compared to the previous year's 50,000. Losses were -20.56 million, -63.24% less than in 2024.

Financial Statements